Suche
Sie versenden diese PresseMitteilung an DGAP-News: Apricus Biosciences Will Request Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Switzerland, Based on Guidance From Swiss Regulatory Authorities Ihren Freund mit dem Namen:
